## ROP: Roper Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.5% below STRENGTH zone (3.0-6.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($431.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 1)

**1. 2,300 Shares in Roper Technologies, Inc. $ROP Acquired by Stance Capital LLC**
- Source: MarketBeat | 20251215T120853 | Neutral | Relevance: 100%
- Stance Capital LLC acquired 2,300 shares of Roper Technologies, Inc. (NASDAQ:ROP) valued at approximately $1,304,000 during the second quarter, as reported in their latest SEC filing. Other institutional investors like Vanguard Group Inc., Price T Rowe Associates Inc. MD, T. Rowe Price Investment Management Inc., State Street Corp, and Geode Capital Management LLC also adjusted their positions in the industrial products company. Analysts have provided mixed ratings for Roper Technologies, with a consensus of "Moderate Buy" and an average target price of $577.15, while insider transactions included both a significant sale by the CEO and a purchase by a director.

**2. Beck Mack & Oliver LLC Acquires 2,659 Shares of Roper Technologies, Inc. $ROP**
- Source: MarketBeat | 20251213T095105 | Somewhat-Bullish | Relevance: 100%
- Beck Mack & Oliver LLC recently increased its stake in Roper Technologies by 1.2% in Q2, acquiring 2,659 shares to hold a total of 226,438 shares, valued at approximately $128.35 million. This makes Roper Technologies the 17th largest position for the firm, accounting for 2.5% of its holdings. The company also announced an increased quarterly dividend of $0.91, and insiders, including CEO Laurence Hunn, have shown confidence by purchasing additional shares.

**3. Strength in Technology Enabled Products Drives Roper: Can It Sustain?**
- Source: TradingView | 20251212T140839 | Somewhat-Bullish | Relevance: 100%
- Roper Technologies, Inc. (ROP) is experiencing strong growth in its Technology Enabled Products segment, driven by robust performance in medical products, ultrasonic meters, and cloud-based software solutions. The company anticipates low-single-digit organic revenue growth for this segment in Q4 2025 and an overall revenue increase of 12.9% for 2025. Despite this growth, Roper's shares have underperformed the industry in the last three months, and analyst estimates for 2025 and 2026 earnings have declined, leading to a Zacks Rank #3 (Hold).

**4. Does Roper Technologies’ 2025 Slide Create a Long Term Opportunity for Investors?**
- Source: Simply Wall Street | 20251211T200850 | Bullish | Relevance: 100%
- Roper Technologies (NasdaqGS: ROP) has seen its stock slide by 13.9% year-to-date and 19.1% over the last year, despite being a high-quality software and technology conglomerate. This decline is attributed more to market re-rating of long-duration assets than company-specific issues, as the company continues to focus on asset-light software businesses. Simply Wall St's analysis, using a Discounted Cash Flow model and Price vs. Earnings multiple, suggests the stock is currently undervalued, offering a potential opportunity for long-term investors.

**5. Does Roper Technologies’ 2025 Slide Create a Long Term Opportunity for Investors?**
- Source: Simply Wall Street | 20251211T200845 | Bullish | Relevance: 100%
- Roper Technologies (NasdaqGS:ROP) has seen its stock slide by 13.9% year-to-date and 19.1% over the last year, despite being a high-quality software and technology conglomerate. This downturn is attributed to market re-ratings rather than company-specific issues, and the company's focus on asset-light software businesses suggests potential for future growth. Valuation analysis indicates Roper is currently undervalued, with a Discounted Cash Flow model suggesting a 38.1% discount and a Price to Earnings multiple showing it is modestly undervalued compared to its fair ratio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $475 | $506 | -6% |
| 2025-11-20 | Piper Sandler | $600 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Underweight |
| 2025-11-20 | Piper Sandler | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($2.47M) |
| Sells | 2 ($0.77M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.8%)
- Blackrock Inc.: 8.6% (-2.1%)
- State Street Corpora: 4.7% (+0.9%)
- Morgan Stanley: 3.7% (+6.8%)
- JPMORGAN CHASE & CO: 3.0% (+225.1%)

### Key Risks

1. Long-term trend broken: trading 16.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 20.6x stretched relative to 8% growth. Quality metrics strong (margin 20%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($2.5M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $48.0B |
| Beta | 0.94 |
| 52W Range | $435.42 - $595.17 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 20.6 |
| Current P/E | 22.4 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.6% to 1.5% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. Below SMA200 (0.84x), long-term trend not supportive. MACD histogram positive (1.71), confirming momentum. RSI neutral at 45. OFD pattern: +DUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.48% (CS: 46) | Neutral |
| RSI_14 | 44.6 | Neutral |
| MACD Histogram | 1.71 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.958x | Below |
| vs SMA200 | 0.840x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $445.86
- **Stop Loss:** $431.24 (3.3% risk)
- **Target:** $460.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $30,318.48
- **Portfolio %:** 30.32%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-29 (Est: $5.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.11 | $5.14 | +0.6% |
| 2025Q2 | $4.83 | $4.87 | +0.8% |
| 2025Q1 | $4.74 | $4.78 | +0.8% |
| 2024Q4 | $4.73 | $4.81 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*